{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T06:43:01Z","timestamp":1787726581967,"version":"build-2784847793"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T00:00:00Z","timestamp":1768435200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"vor","delay-in-days":26,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100002426","name":"Fondazione Telethon","doi-asserted-by":"publisher","award":["GGP20130"],"award-info":[{"award-number":["GGP20130"]}],"id":[{"id":"10.13039\/501100002426","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002426","name":"Fondazione Telethon","doi-asserted-by":"publisher","award":["GGP20130"],"award-info":[{"award-number":["GGP20130"]}],"id":[{"id":"10.13039\/501100002426","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["MSCA_0000055"],"award-info":[{"award-number":["MSCA_0000055"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031478","name":"NextGenerationEU","doi-asserted-by":"publisher","award":["Generation D initiative"],"award-info":[{"award-number":["Generation D initiative"]}],"id":[{"id":"10.13039\/100031478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["Z1A HD008920"],"award-info":[{"award-number":["Z1A HD008920"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010434","name":"'la Caixa' Foundation","doi-asserted-by":"publisher","award":["100010434"],"award-info":[{"award-number":["100010434"]}],"id":[{"id":"10.13039\/100010434","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Centre Hospitalier Universitaire de Li\u00e8ge","award":["Fonds d\u2019Investissment pour la Recherche Scientifique 2018-2023"],"award-info":[{"award-number":["Fonds d\u2019Investissment pour la Recherche Scientifique 2018-2023"]}]},{"DOI":"10.13039\/501100005627","name":"Universit\u00e9 de Li\u00e8ge","doi-asserted-by":"publisher","award":["FSR-F-2023-FM"],"award-info":[{"award-number":["FSR-F-2023-FM"]}],"id":[{"id":"10.13039\/501100005627","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Genom. Med."],"DOI":"10.1038\/s41525-025-00548-7","type":"journal-article","created":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T06:06:20Z","timestamp":1768457180000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Distinguishing benign from pathogenic duplications involving GPR101 and VGLL1-adjacent enhancers in the clinical setting with the bioinformatic tool POSTRE"],"prefix":"10.1038","volume":"11","author":[{"given":"Giampaolo","family":"Trivellin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00edctor","family":"S\u00e1nchez-Gaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexia","family":"Grasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Pasi\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantine A.","family":"Stratakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Milnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin P.","family":"Kirk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Beckers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea G.","family":"Lania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"P\u00e9trossians","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvaro","family":"Rada-Iglesias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Franke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian F.","family":"Daly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,15]]},"reference":[{"key":"548_CR1","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/nature11082","volume":"485","author":"JR Dixon","year":"2012","unstructured":"Dixon, J. R. et al. Topological domains in mammalian genomes identified by analysis of chromatin interactions. Nature 485, 376\u2013380 (2012).","journal-title":"Nature"},{"key":"548_CR2","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1002\/bies.201300040","volume":"35","author":"EP Nora","year":"2013","unstructured":"Nora, E. P., Dekker, J. & Heard, E. Segmental folding of chromosomes: a basis for structural and regulatory chromosomal neighborhoods? Bioessays 35, 818\u2013828 (2013).","journal-title":"Bioessays"},{"key":"548_CR3","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.tig.2016.01.003","volume":"32","author":"DG Lupianez","year":"2016","unstructured":"Lupianez, D. G., Spielmann, M. & Mundlos, S. Breaking TADs: how alterations of chromatin domains result in disease. Trends Genet 32, 225\u2013237 (2016).","journal-title":"Trends Genet"},{"key":"548_CR4","doi-asserted-by":"publisher","first-page":"102048","DOI":"10.1016\/j.gde.2023.102048","volume":"80","author":"J Weischenfeldt","year":"2023","unstructured":"Weischenfeldt, J. & Ibrahim, D. M. When 3D genome changes cause disease: the impact of structural variations in congenital disease and cancer. Curr. Opin. Genet Dev. 80, 102048 (2023).","journal-title":"Curr. Opin. Genet Dev."},{"key":"548_CR5","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/s41576-018-0007-0","volume":"19","author":"M Spielmann","year":"2018","unstructured":"Spielmann, M., Lupianez, D. G. & Mundlos, S. Structural variation in the 3D genome. Nat. Rev. Genet 19, 453\u2013467, (2018).","journal-title":"Nat. Rev. Genet"},{"key":"548_CR6","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/s41436-020-00974-1","volume":"23","author":"E D\u2019Haene","year":"2021","unstructured":"D\u2019Haene, E. & Vergult, S. Interpreting the impact of noncoding structural variation in neurodevelopmental disorders. Genet. Med. 23, 34\u201346 (2021).","journal-title":"Genet. Med."},{"key":"548_CR7","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.gde.2016.03.008","volume":"36","author":"AL Valton","year":"2016","unstructured":"Valton, A. L. & Dekker, J. TAD disruption as oncogenic driver. Curr. Opin. Genet Dev. 36, 34\u201340 (2016).","journal-title":"Curr. Opin. Genet Dev."},{"key":"548_CR8","doi-asserted-by":"publisher","first-page":"e1005640","DOI":"10.1371\/journal.pgen.1005640","volume":"11","author":"N Matharu","year":"2015","unstructured":"Matharu, N. & Ahituv, N. Minor loops in major folds: enhancer-promoter looping, chromatin restructuring, and their association with transcriptional regulation and disease. PLoS Genet. 11, e1005640 (2015).","journal-title":"PLoS Genet."},{"key":"548_CR9","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/s42003-023-04819-w","volume":"6","author":"S Rajderkar","year":"2023","unstructured":"Rajderkar, S. et al. Topologically associating domain boundaries are required for normal genome function. Commun. Biol. 6, 435 (2023).","journal-title":"Commun. Biol."},{"key":"548_CR10","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1056\/NEJMoa1408028","volume":"371","author":"G Trivellin","year":"2014","unstructured":"Trivellin, G. et al. Gigantism and acromegaly due to Xq26 microduplications and GPR101 mutation. N. Engl. J. Med. 371, 2363\u20132374 (2014).","journal-title":"N. Engl. J. Med."},{"key":"548_CR11","doi-asserted-by":"publisher","first-page":"1345363","DOI":"10.3389\/fendo.2024.1345363","volume":"15","author":"M Caruso","year":"2024","unstructured":"Caruso, M. et al. Case report: management of pediatric gigantism caused by the TADopathy, X-linked acrogigantism. Front. Endocrinol. (Lausanne) 15, 1345363 (2024).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"548_CR12","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.ajhg.2022.02.002","volume":"109","author":"M Franke","year":"2022","unstructured":"Franke, M. et al. Duplications disrupt chromatin architecture and rewire GPR101-enhancer communication in X-linked acrogigantism. Am. J. Hum. Genet 109, 553\u2013570 (2022).","journal-title":"Am. J. Hum. Genet"},{"key":"548_CR13","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1002\/ana.27038","volume":"96","author":"P Dimartino","year":"2024","unstructured":"Dimartino, P. et al. Structural Variants at the LMNB1 locus: deciphering pathomechanisms in autosomal dominant adult-onset demyelinating leukodystrophy. Ann. Neurol. 96, 855\u2013870 (2024).","journal-title":"Ann. Neurol."},{"key":"548_CR14","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s13073-024-01378-5","volume":"16","author":"AF Daly","year":"2024","unstructured":"Daly, A. F. et al. Chromatin conformation capture in the clinic: 4C-seq\/HiC distinguishes pathogenic from neutral duplications at the GPR101 locus. Genome Med 16, 112 (2024).","journal-title":"Genome Med"},{"key":"548_CR15","doi-asserted-by":"publisher","first-page":"e54","DOI":"10.1093\/nar\/gkad225","volume":"51","author":"V Sanchez-Gaya","year":"2023","unstructured":"Sanchez-Gaya, V. & Rada-Iglesias, A. POSTRE: a tool to predict the pathological effects of human structural variants. Nucleic Acids Res 51, e54 (2023).","journal-title":"Nucleic Acids Res"},{"key":"548_CR16","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s40478-016-0328-1","volume":"4","author":"D Iacovazzo","year":"2016","unstructured":"Iacovazzo, D. et al. Germline or somatic GPR101 duplication leads to X-linked acrogigantism: a clinico-pathological and genetic study. Acta Neuropathol. Commun. 4, 56 (2016).","journal-title":"Acta Neuropathol. Commun."},{"key":"548_CR17","doi-asserted-by":"publisher","first-page":"luad028","DOI":"10.1210\/jcemcr\/luad028","volume":"1","author":"CP Burren","year":"2023","unstructured":"Burren, C. P., Williams, G., Coxson, E. & Korbonits, M. Effective long-term pediatric pegvisomant monotherapy to final height in x-linked acrogigantism. JCEM Case Rep. 1, luad028 (2023).","journal-title":"JCEM Case Rep."},{"key":"548_CR18","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41588-017-0035-2","volume":"50","author":"A Mayran","year":"2018","unstructured":"Mayran, A. et al. Pioneer factor Pax7 deploys a stable enhancer repertoire for specification of cell fate. Nat. Genet. 50, 259\u2013269 (2018).","journal-title":"Nat. Genet."},{"key":"548_CR19","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.celrep.2014.09.023","volume":"9","author":"MW Vermunt","year":"2014","unstructured":"Vermunt, M. W. et al. Large-scale identification of coregulated enhancer networks in the adult human brain. Cell Rep. 9, 767\u2013779 (2014).","journal-title":"Cell Rep."},{"key":"548_CR20","doi-asserted-by":"publisher","first-page":"688","DOI":"10.3389\/fgene.2020.00688","volume":"11","author":"V Sanchez-Gaya","year":"2020","unstructured":"Sanchez-Gaya, V., Mariner-Fauli, M. & Rada-Iglesias, A. Rare or overlooked? structural disruption of regulatory domains in human neurocristopathies. Front. Genet. 11, 688 (2020).","journal-title":"Front. Genet."},{"key":"548_CR21","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s11102-025-01559-4","volume":"28","author":"C Hilditch","year":"2025","unstructured":"Hilditch, C., Curtis, S., Cotton, S., LeBlanc, S. & De Sousa, S. Non-penetrant Xq26.3 duplication involving the invariant TAD border: clinical evidence for the VGLL1 region as the GPR101 pituitary enhancer of X-linked acrogigantism. Pituitary 28, 85 (2025).","journal-title":"Pituitary"},{"key":"548_CR22","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/nrg3663","volume":"15","author":"CT Ong","year":"2014","unstructured":"Ong, C. T. & Corces, V. G. CTCF: an architectural protein bridging genome topology and function. Nat. Rev. Genet. 15, 234\u2013246 (2014).","journal-title":"Nat. Rev. Genet."},{"key":"548_CR23","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/j.molcel.2017.08.026","volume":"67","author":"G Ren","year":"2017","unstructured":"Ren, G. et al. CTCF-Mediated enhancer-promoter interaction is a critical regulator of cell-to-cell variation of gene expression. Mol. Cell 67, 1049\u20131058 (2017).","journal-title":"Mol. Cell"},{"key":"548_CR24","doi-asserted-by":"publisher","first-page":"12390","DOI":"10.1073\/pnas.1900672116","volume":"116","author":"C Paliou","year":"2019","unstructured":"Paliou, C. et al. Preformed chromatin topology assists transcriptional robustness of Shh during limb development. Proc. Natl. Acad. Sci. USA 116, 12390\u201312399 (2019).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"548_CR25","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.beem.2018.02.004","volume":"32","author":"G Trivellin","year":"2018","unstructured":"Trivellin, G., Hernandez-Ramirez, L. C., Swan, J. & Stratakis, C. A. An orphan G-protein-coupled receptor causes human gigantism and\/or acromegaly: moleCular biology and clinical correlations. Best. Pr. Res. Clin. Endocrinol. Metab. 32, 125\u2013140 (2018).","journal-title":"Best. Pr. Res. Clin. Endocrinol. Metab."},{"key":"548_CR26","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1210\/endrev\/bnae014","volume":"45","author":"AF Daly","year":"2024","unstructured":"Daly, A. F. & Beckers, A. The genetic pathophysiology and clinical management of the tadopathy, x-linked acrogigantism. Endocr. Rev. 45, 737\u2013754 (2024).","journal-title":"Endocr. Rev."},{"key":"548_CR27","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1530\/ERC-15-0478","volume":"23","author":"AF Daly","year":"2016","unstructured":"Daly, A. F. et al. GHRH excess and blockade in X-LAG syndrome. Endocr. Relat. Cancer 23, 161\u2013170 (2016).","journal-title":"Endocr. Relat. Cancer"},{"key":"548_CR28","doi-asserted-by":"publisher","first-page":"4752","DOI":"10.1038\/s41467-020-18500-x","volume":"11","author":"D Abboud","year":"2020","unstructured":"Abboud, D. et al. GPR101 drives growth hormone hypersecretion and gigantism in mice via constitutive activation of Gs and Gq\/11. Nat. Commun. 11, 4752 (2020).","journal-title":"Nat. Commun."},{"key":"548_CR29","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1530\/JME-16-0045","volume":"57","author":"G Trivellin","year":"2016","unstructured":"Trivellin, G. et al. Characterization of GPR101 transcript structure and expression patterns. J. Mol. Endocrinol. 57, 97\u2013111 (2016).","journal-title":"J. Mol. Endocrinol."},{"key":"548_CR30","doi-asserted-by":"publisher","first-page":"5826","DOI":"10.1016\/j.cell.2023.11.030","volume":"186","author":"JW Blayney","year":"2023","unstructured":"Blayney, J. W. et al. Super-enhancers include classical enhancers and facilitators to fully activate gene expression. Cell 186, 5826\u20135839 (2023).","journal-title":"Cell"},{"key":"548_CR31","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/ame2.12032","volume":"1","author":"Y Peng","year":"2018","unstructured":"Peng, Y. & Zhang, Y. Enhancer and super-enhancer: positive regulators in gene transcription. Anim. Model Exp. Med. 1, 169\u2013179 (2018).","journal-title":"Anim. Model Exp. Med."},{"key":"548_CR32","doi-asserted-by":"publisher","unstructured":"Plaisancie, J. et al. Structural variant disrupting the expression of the remote FOXC1 gene in a patient with syndromic complex microphthalmia. Int. J. Mol. Sci. 25 (2024). https:\/\/doi.org\/10.3390\/ijms25052669.","DOI":"10.3390\/ijms25052669"},{"key":"548_CR33","doi-asserted-by":"publisher","unstructured":"Hamerlinck, L. et al. Non-coding structural variants identify a commonly affected regulatory region steering FOXG1 transcription in early neurodevelopment. medRxiv, 2025.2003.20 https:\/\/doi.org\/10.1101\/2025.03.10.25323301.","DOI":"10.1101\/2025.03.10.25323301"},{"key":"548_CR34","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s10048-024-00774-8","volume":"25","author":"P Carballo-Pacoret","year":"2024","unstructured":"Carballo-Pacoret, P., Carracedo, A. & Rodriguez-Fontenla, C. Unraveling the three-dimensional (3D) genome architecture in Neurodevelopmental Disorders (NDDs). Neurogenetics 25, 293\u2013305, https:\/\/doi.org\/10.1007\/s10048-024-00774-8 (2024).","journal-title":"Neurogenetics"},{"key":"548_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s11658-022-00409-6","volume":"28","author":"L Zhang","year":"2023","unstructured":"Zhang, L. et al. Three-dimensional genome landscape comprehensively reveals patterns of spatial gene regulation in papillary and anaplastic thyroid cancers: a study using representative cell lines for each cancer type. Cell Mol. Biol. Lett. 28, 1 (2023).","journal-title":"Cell Mol. Biol. Lett."},{"key":"548_CR36","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1093\/biolre\/ioaf017","volume":"112","author":"AC Lima","year":"2025","unstructured":"Lima, A. C. et al. Deletion of an evolutionarily conserved TAD boundary impacts spermatogenesis in mice. Biol. Reprod. 112, 767\u2013779 (2025).","journal-title":"Biol. Reprod."},{"key":"548_CR37","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.ajhg.2020.09.002","volume":"107","author":"SE de Bruijn","year":"2020","unstructured":"de Bruijn, S. E. et al. Structural variants create new topological-associated domains and ectopic retinal enhancer-gene contact in dominant retinitis pigmentosa. Am. J. Hum. Genet. 107, 802\u2013814 (2020).","journal-title":"Am. J. Hum. Genet."},{"key":"548_CR38","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1530\/ERC-15-0038","volume":"22","author":"A Beckers","year":"2015","unstructured":"Beckers, A. et al. X-linked acrogigantism syndrome: clinical profile and therapeutic responses. Endocr. Relat. Cancer 22, 353\u2013367 (2015).","journal-title":"Endocr. Relat. Cancer"},{"key":"548_CR39","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1007\/s12020-015-0804-6","volume":"51","author":"LA Naves","year":"2016","unstructured":"Naves, L. A. et al. Aggressive tumor growth and clinical evolution in a patient with X-linked acro-gigantism syndrome. Endocrine 51, 236\u2013244 (2016).","journal-title":"Endocrine"},{"key":"548_CR40","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1007\/s11102-020-01105-4","volume":"24","author":"EB Trarbach","year":"2021","unstructured":"Trarbach, E. B. et al. Genetics, clinical features and outcomes of non-syndromic pituitary gigantism: experience of a single center from Sao Paulo, Brazil. Pituitary 24, 252\u2013261 (2021).","journal-title":"Pituitary"},{"key":"548_CR41","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1007\/s11102-016-0743-0","volume":"19","author":"RJ Gordon","year":"2016","unstructured":"Gordon, R. J. et al. Childhood acromegaly due to X-linked acrogigantism: long term follow-up. Pituitary 19, 560\u2013564 (2016).","journal-title":"Pituitary"},{"key":"548_CR42","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1159\/000512240","volume":"111","author":"H Liang","year":"2021","unstructured":"Liang, H. et al. A Chinese Case of X-Linked Acrogigantism and Systematic Review. Neuroendocrinology 111, 1164\u20131175 (2021).","journal-title":"Neuroendocrinology"},{"key":"548_CR43","doi-asserted-by":"publisher","first-page":"27","DOI":"10.2147\/TACG.S357136","volume":"15","author":"M Pasinska","year":"2022","unstructured":"Pasinska, M. et al. Clinical importance of acgh in genetic counselling of children with psychomotor retardation. Appl Clin. Genet. 15, 27\u201338 (2022).","journal-title":"Appl Clin. Genet."},{"key":"548_CR44","doi-asserted-by":"publisher","unstructured":"Yu, S. et al. The 3D Genome Browser 2.0: an enhanced online platform for visualizing and analyzing 3D genome architecture. Nucleic Acids Res (2025). https:\/\/doi.org\/10.1093\/nar\/gkaf1109.","DOI":"10.1093\/nar\/gkaf1109"},{"key":"548_CR45","doi-asserted-by":"publisher","first-page":"D1243","DOI":"10.1093\/nar\/gkae974","volume":"53","author":"G Perez","year":"2025","unstructured":"Perez, G. et al. The UCSC Genome Browser database: 2025 update. Nucleic Acids Res. 53, D1243\u2013D1249, https:\/\/doi.org\/10.1093\/nar\/gkae974 (2025).","journal-title":"Nucleic Acids Res."},{"key":"548_CR46","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1038\/s41588-019-0538-0","volume":"51","author":"CP Fulco","year":"2019","unstructured":"Fulco, C. P. et al. Activity-by-contact model of enhancer-promoter regulation from thousands of CRISPR perturbations. Nat. Genet. 51, 1664\u20131669 (2019).","journal-title":"Nat. Genet."}],"container-title":["npj Genomic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41525-025-00548-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41525-025-00548-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41525-025-00548-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T03:06:59Z","timestamp":1770779219000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41525-025-00548-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,15]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["548"],"URL":"https:\/\/doi.org\/10.1038\/s41525-025-00548-7","relation":{},"ISSN":["2056-7944"],"issn-type":[{"value":"2056-7944","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,15]]},"assertion":[{"value":"10 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"AFD, CAS, and GT hold a patent on GPR101 and its function (US Patent No. 10,350,273, Treatment of Hormonal Disorders of Growth). The authors declare no other competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12"}}